Arbidol: a quarter-century later. Past, present and future of the original Russian antiviral
Konstantin V. Balakinab, Rosanna Filosacde, Sergey N. Lavrenovf, Arthur S. Mkrtchyang, Maxim B. Nawrozkijg, Ivan A. Novakovg
a Kazan (Volga Region) Federal University
b I. M. Sechenov First Moscow State Medical University
c Department of Experimental Medicine, Section of Biotechnology, University of Campania "Luigi Vanvitelli", Italy
d Consorzio Sannio Tech, Italy
e Institute of Food Sciences, National Research Council, Italy
f Gause Institute of New Antibiotics, Moscow
g Volgograd State Technical University
The present review relates to the synthesis and structure-activity relationship studies of Arbidol and its structural analogues. The latter are roughly divided into several unequal parts: indole- and benzofuran-based compounds, benzimidazole and imidazopyridine bioisosteres, and ring-expanded quinoline derivatives. Much attention is focused on various types of antiviral activity of the above-mentioned Arbidol congeners, as well as of the parent compound itself. Features of Arbidol synthesis and metabolic changes are also discussed.
Bibliography — 166 references.
Russian Chemical Reviews, 2018, 87:6, 509–552
Konstantin V. Balakin, Rosanna Filosa, Sergey N. Lavrenov, Arthur S. Mkrtchyan, Maxim B. Nawrozkij, Ivan A. Novakov, “Arbidol: a quarter-century later. Past, present and future of the original Russian antiviral”, Usp. Khim., 87:6 (2018), 509–552; Russian Chem. Reviews, 87:6 (2018), 509–552
Citation in format AMSBIB
\by Konstantin~V.~Balakin, Rosanna~Filosa, Sergey~N.~Lavrenov, Arthur~S.~Mkrtchyan, Maxim~B.~Nawrozkij, Ivan~A.~Novakov
\paper Arbidol: a quarter-century later. Past, present and future of the original Russian antiviral
\jour Usp. Khim.
\jour Russian Chem. Reviews
Citing articles on Google Scholar:
Related articles on Google Scholar:
|Number of views:|